AMNEAL PHARMACEUTICALS, INC. Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal
AMNEAL PHARMACEUTICALS, INC. (AMRX) reported Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-03.
Discontinued › Income Statement › Other Income
us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal · last filed 2023-03-03
- AMNEAL PHARMACEUTICALS, INC. disposal group, not discontinued operation, gain (loss) on disposal for the quarter ending 2021-12-31 was $0.00.
- AMNEAL PHARMACEUTICALS, INC. disposal group, not discontinued operation, gain (loss) on disposal for the quarter ending 2021-09-30 was $0.00.
- AMNEAL PHARMACEUTICALS, INC. disposal group, not discontinued operation, gain (loss) on disposal for the quarter ending 2021-06-30 was $0.00, a 100.00% decline year-over-year.
- AMNEAL PHARMACEUTICALS, INC. disposal group, not discontinued operation, gain (loss) on disposal for the quarter ending 2020-12-31 was $0.00, a 100.00% decline year-over-year.
- AMNEAL PHARMACEUTICALS, INC. disposal group, not discontinued operation, gain (loss) on disposal for fiscal 2022 was $0.00.
- AMNEAL PHARMACEUTICALS, INC. disposal group, not discontinued operation, gain (loss) on disposal for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- AMNEAL PHARMACEUTICALS, INC. disposal group, not discontinued operation, gain (loss) on disposal for fiscal 2020 was $123.00K, a 98.31% decline from fiscal 2019.
- AMNEAL PHARMACEUTICALS, INC. disposal group, not discontinued operation, gain (loss) on disposal for fiscal 2019 was $7.26M.
| Period end | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 3 month | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 6 month | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 9 month | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-03 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | $0.00 derived: sum of 2 quarters · filed 2023-03-03 | $0.00 derived: sum of 3 quarters · filed 2023-03-03 | $0.00 10-K · filed 2023-03-03 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-08 | $0.00 derived: sum of 2 quarters · filed 2021-11-08 | $0.00 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-09 | $0.00 10-Q · filed 2021-08-09 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | $0.00 derived: sum of 2 quarters · filed 2023-03-03 | $123.00K derived: sum of 3 quarters · filed 2023-03-03 | $123.00K 10-K · filed 2023-03-03 |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-08 | $123.00K derived: sum of 2 quarters · filed 2021-11-08 | $123.00K 10-Q · filed 2021-11-08 | $451.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $123.00K 10-Q · filed 2021-08-09 | $123.00K 10-Q · filed 2021-08-09 | $451.00K derived: sum of 3 quarters · filed 2022-03-01 | $451.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-11 | $328.00K derived: sum of 2 quarters · filed 2022-03-01 | $328.00K derived: sum of 3 quarters · filed 2022-03-01 | -$1.56M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $328.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $328.00K derived: sum of 2 quarters · filed 2022-03-01 | -$1.56M derived: sum of 3 quarters · filed 2022-03-01 | $7.26M 10-K · filed 2022-03-01 |
| 2019-09-30 | $0.00 10-Q · filed 2020-11-06 | -$1.89M derived: sum of 2 quarters · filed 2020-11-06 | $6.93M 10-Q · filed 2020-11-06 | $6.78M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | -$1.89M 10-Q · filed 2020-08-06 | $6.93M 10-Q · filed 2020-08-06 | $6.78M derived: sum of 3 quarters · filed 2021-03-01 | $3.97M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $8.82M 10-Q · filed 2020-05-11 | $8.67M derived: sum of 2 quarters · filed 2021-03-01 | $5.86M derived: sum of 3 quarters · filed 2021-03-01 | $5.86M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | -$146.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$2.96M derived: sum of 2 quarters · filed 2021-03-01 | -$2.96M derived: sum of 3 quarters · filed 2021-03-01 | -$2.96M 10-K · filed 2021-03-01 |
| 2018-09-30 | -$2.81M 10-Q · filed 2019-11-07 | -$2.81M derived: sum of 2 quarters · filed 2019-11-07 | -$2.81M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $0.00 10-Q · filed 2019-08-05 | $0.00 10-Q · filed 2019-08-05 | ||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-09 | |||
| 2017-12-31 | -$29.23M 10-K · filed 2020-03-02 | |||
| 2016-12-31 | $0.00 10-K · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |